Hemozoin polymerization and hemoglobin digestion machinery

The hemozoin polymerization and hemoglobin digestion machinery is a specialized metabolic system within Plasmodium-infected erythrocytes that is essential for the parasite's survival. During its intraerythrocytic stage, the parasite ingests host hemoglobin and transports it to an acidic food vacuole, where a suite of enzymes—including plasmepsins and falcipains—degrade the protein into amino acids for parasite protein synthesis (Goldberg, 2005). This process releases free heme (ferriprotoporphyrin IX), a toxic byproduct that can cause oxidative damage and membrane lysis. To prevent self-destruction, the parasite utilizes a biomineralization process to sequester free heme into chemically inert crystals called hemozoin, or malarial pigment (Sullivan, 2002). This machinery is a validated therapeutic target; classic antimalarials like chloroquine and quinine interfere with heme crystallization, causing toxic heme to accumulate and kill the parasite (Egan, 2008). Modern drug discovery also targets the specific proteases involved in the initial hemoglobin breakdown to bypass existing resistance mechanisms (Warhurst, 2001).

Other names

Heme detoxification pathwayHemozoin formationHemoglobin degradation pathwayMalarial pigment formationHeme biocrystallization

Drugs primarily act by binding to heme monomers or the growing surface of hemozoin crystals, preventing further polymerization and leading to the accumulation of toxic free heme (Egan, 2008). Additionally, some inhibitors target the aspartic proteases (plasmepsins) and cysteine proteases (falcipains) that catalyze the initial stages of hemoglobin degradation (Goldberg, 2005).